In vitro and ex vivo assessment of hydrophilic polymer‐ and plasticizer‐based thin buccal films designed by using central composite rotatable design for the delivery of meloxicam

Abstract

The purpose of the study was to design a dosage form with ability to deliver drug immediately, hence providing rapid relief in certain pain ailments. Meloxicam (MLX) was selected as a model drug and buccal films were designed by using the solvent casting technique. A central composite rotatable design (CCRD) was used as a statistical tool to design and optimize the film formulations. No noticeable interaction was found between the drug and polymer when they were subjected to Fourier transform infrared spectroscopy (FTIR). Scanning electron microscopy (SEM) revealed the smooth surface of the film and uniform mixing of drug and polymer.X-ray diffractometry (XRD) was carried out to observe crystalline and amorphous nature of meloxicam. Differential scanning calorimetric (DSC) analysis was used to investigate the thermal behavior of free drug and drug-loaded formulation. The prepared film showed good mechanical property as folding endurance was found to be greater than 100 in all formulations. The cumulative drug release was found to be more than 80% in initial at dissolution time of 5 min, when the prepared films were subjected to dissolution studies in phosphate buffer at pH 6.8. Thus, it can be concluded that the hydrophilic polymer and plasticizer have definite impact on formulation and characteristics of rapidly dissolving buccal films and have the ability to prepare a suitable immediate release buccal film of meloxicam. K E Y W O R D Sbuccal films, drug delivery system, ex-vivo permeation, hydrophilic polymer, meloxicam, plasticizer, solvent casting method

Transdermal patch, co-loaded with Pregabalin and Ketoprofen for improved bioavailability; in vitro studies

“…The independence of drug release from the initial concentration was judged by the values of coefficient of correlation (R 2 ) of zero-order kinetics while the drug release mechanism was arbitrated by the values of R 2 of Korsmeyer-Peppas model. 29,30 Values were greater than 0.9 in all the cases; however, the value of “n” has suggested that the drug release is following super case II transport (n > 0.89). 31…”

The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach

“…Polynomial Equation (7) describes that the TDT and polymer have a constructive impact on TDT. A negative sign for plasticizers represents a decrease in TDT [ 79 ]. TDT ranges from 40.5 ± 1 for F4 to a minimum of 22 ± 1 for F7.…”

“…A drug release of a maximum of 102.61 ± 1.13% for F7 and the lowest release of 74.5 ± 1.15% for F2 was observed, as shown in Figure 6 . Using polynomial Equation (12), the X1 variable has a negative value, indicating that the drug release would decrease if the polymer concentration increased [ 79 ]. The possible justification was that the increased polymer concentration increases the polymer meshwork, and the drug’s release decreases [ 87 ].…”

Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers

“…Each dialysis membrane was filled with 1 mL of each formulation and tied at both ends. Then these membranes were hung by a thread to the paddles of each vessel that had been already filled with the buffer solution . The samples (1 mL) were taken out from each vessel, suitably diluted, and then subjected to UV analysis.…”